Epigenetic protein families: a new frontier for drug discovery
The DOI matches its Crossref record; 192 of the 194 references it cites were found in a registry or an index.
Abstract
Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones. Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-containing proteins and proteins that bind to methylated histones. These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains. In this article, we discuss the known links with disease, basic molecular mechanisms of action and recent progress in the pharmacological modulation of each class of proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They have also been demonstrated to possess greater isoform selectivity profiles, targeting specifically only the class I subgroup of HDACs (6-10, 26, 38, 39).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [7]
In the citing paper
“The benzamides face a more difficult path to the observed binding mode, with two plausible binding trajectories. The ligand could enter via an acetyl release and disposal channel (7, 24, 33, 42) or via the hydrophobic tube, settling into a rearranged foot pocket before forming the zinc complex, which locks the inhibitor in place.”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [7]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599
Research works printed but not linked: 1
- Allis, C. D., Jenuwein, T. & Reinberg, D. Epigenetics (Cold Spring Harbor Laboratory Press, New York, 2007).
Cited by
Items 901–1,000 of 1,001
SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells
Biton, T. E., Feldman, M., Davidy, T., Moskovitz, N. T., Levin, L., Sevilla-Sánchez, D., Goding, C. R., Bernstein, E., & Levy, D. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf023 · Cited by 8
“There are ∼ 50 members of the PKMT family, of which most contain a conserved Su(var), enhancer of zeste, trithorax (SET) domain, which is responsible for the enzymatic activity [ 17 ].”
InfluentialStructural and Functional Studies on Key Epigenetic Regulators in Asthma
李文锦, Fakhar, M., & Gul, M. (2025) · Biomolecules · doi:10.3390/biom15091255 · Cited by 11
“Epigenetic modifications, which include DNA methylation, histone modifications, chromatin remodeling, and RNA regulation are dynamically regulated by a myriad of epigenetically important proteins, which act as writers, erasers, and readers of epigenetic marks [18].”
Synthesis of lysine methyltransferase inhibitors
Hui, C., & Ye, T. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00044 · Cited by 10
“Recent basic studies on histone methyltransferases indicated that deregulation of histone methylation plays a critical role in human carcinogenesis (Copeland et al., 2009; Spannhoff et al., 2009; Chi et al., 2010; Arrowsmith et al., 2012; Helin and Dhanak, 2013).”
BackgroundEpigenetic Molecular Recognition: A Biomolecular Modeling Perspective
Vellore, N. A., & Baron, R. (2014) · ChemMedChem · doi:10.1002/cmdc.201300510 · Cited by 11
Mining the topography and dynamics of the 4D Nucleome to identify novel CNS drug pathways
Higgins, G. A., Allyn-Feuer, A., Georgoff, P. E., Nikolian, V. C., Alam, H. B., & Athey, B. D. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.012 · Cited by 11
A primer on metabolic memory: why existing diabesity treatments fail
Çöpür, S., Rossing, P. R., Afşar, B., Sag, A. A., Siriopol, D. C., Kuwabara, M., Ortíz, A., & Kanbay, M. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa143 · Cited by 11
“Epigenetic alterations have been utilized in the treatment of oncological, autoimmune and neurological diseases with promising outcomes, such as four histone deacetylase inhibitors (vorinostat, romidepsin, panobinostat and belinostat) and two DNA methylation inhibitors (azacytidine and decitabine) that are approved by…”
BackgroundZhang, C., Tan, C. Y. J., Ge, J., Na, Z., Chen, G. Y. J., Uttamchandani, M., Sun, H., & Yao, S. Q. (2013) · Angewandte Chemie · doi:10.1002/ange.201307803 · Cited by 10
Phaosiri, C., Yenjai, C., Senawong, T., Senawong, G., Saenglee, S., Somsakeesit, L., & Kumboonma, P. (2022) · Molecules · doi:10.3390/molecules27103332 · Cited by 14
“HDACs have key effects on various cellular functions such as the regulation of gene transcription and cell proliferation, differentiation and death [4,5].”
BackgroundMolteni, E., Baldan, F., Damante, G., & Allegri, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065993 · Cited by 10
“The human proteome encodes 61 BRD modules found in 42 different proteins [12], which can be classified into eight subfamilies based on their sequence and structure [17].”
BackgroundIbrahim, M. A. A., Abdelhamid, M. M. H., Abdeljawaad, K. A. A., Abdelrahman, A. H. M., Mekhemer, G. A. H., Sidhom, P. A., Sayed, S. R. M., Paré, P. W., Hegazy, M. F., & Shoeib, T. (2023) · Molecules · doi:10.3390/molecules28155713 · Cited by 11
“It is known that 46 proteins in the human body contain 61 isoforms of bromodomains (BRDs), which can be categorized into eight groups and have about 140 amino acid residues in their sequences [1,2].”
BackgroundRepurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer’s Agent
Jana, A., Bellver‐Sanchís, A., Griñán‐Ferré, C., & Banerjee, D. R. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00344 · Cited by 10
Kato, S., Ishii, T., & Kouzmenko, A. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.84 · Cited by 12
Native gel analysis of macromolecular protein complexes in cultured mammalian cells
Munawar, N., Olivero, G., Jerman, E., Doyle, B., Streubel, G., Wynne, K. J., Bracken, A. P., & Cagney, G. (2015) · PROTEOMICS · doi:10.1002/pmic.201500045 · Cited by 10
“More protein complexes overall were detected in the chromatin fraction than other fractions, perhaps reflecting the many distinct epigenetic regulators associated with the regulation of gene expression [22].”
BackgroundTargeting components of epigenome by small molecules
You, J. S., & Han, J. H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0455-9 · Cited by 10
“Furthermore, the reversibility of epigenetic modifications makes them more attractive to target using small molecule compounds (Arrowsmith et al. 2012; Kelly et al. 2010).”
BackgroundBioanalytical approaches for the detection of protein acetylation-related enzymes
Li, P. S., Han, Y., Li, Y., Zhu, R., Wang, H., Nie, Z., & Yao, S. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9304-7 · Cited by 10
Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137)
Simões‐Pires, C. A., Bertrand, P., & Cuendet, M. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1282945 · Cited by 10
Helgudóttir, S. S., Lichota, J., Burkhart, A., & Moos, T. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1241-3 · Cited by 10
Bouchet, S., Linot, C., Ružić, D., Agbaba, D. D., Fouchaq, B., Roche, J., Nikolic, K. M., Blanquart, C., & Bertrand, P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00440 · Cited by 10
Druggable Transcriptional Networks in the Human Neurogenic Epigenome
Higgins, G. A., Williams, A. M., Ade, A. S., Alam, H. B., & Athey, B. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017681 · Cited by 10
“…trends impact our understanding of human-drug response mechanisms beyond so-called “ epigenetic drugs ” that modulate readers, writers, and erasers (Arrowsmith et al., 2012), leading to a unifying model of how xenobiotics and endogenous hormones modulate the functional topology of the human genome…”
BackgroundNovel Conjugated Quinazolinone-Based Hydroxamic Acids: Design, Synthesis and Biological Evaluation
Vu, T. K., Thanh, N. T., Minh, N. V., Linh, N. H., Thảo, N. T. P., Nguyen, T. T. B., Hien, D. T., Chinh, L. V., Duc, T. H., Anh, L. D., et al. (2020) · Medicinal Chemistry · doi:10.2174/1573406416666200420081540 · Cited by 10
Wu, S., Zhao, J., Sun, H. B., Li, H.-R., Yin, Y., & Zhang, L. (2021) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2021.1887351 · Cited by 10
CHRAC1 promotes human lung cancer growth through regulating YAP transcriptional activity
Wang, M., Li, S., Guo, W., Wang, L., Huang, J., Zhuo, J., Lai, B., Liao, C., Ge, T., Nie, Y., et al. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab103 · Cited by 12
Wang, L., Wang, Y., Zhao, J., Yu, Y. X., Kang, N.-Q., & Yang, Z. (2022) · RSC Advances · doi:10.1039/d2ra02637f · Cited by 10
Martinez, N. J., & Simeonov, A. M. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.10.004 · Cited by 10
“Comprehensive reviews on histone modifying enzymes are references [1] and [2].”
BackgroundHu, L., Xie, W., Gore, E. R., Montoute, M. N., Bee, W. T., Zappacosta, F., Zeng, X., Wu, Z., Kallal, L. A., Ames, R. S., et al. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113499776 · Cited by 11
Chandran, A., Syed, J., Li, Y., Sato, S., Bando, T., & Sugiyama, H. (2016) · ChemBioChem · doi:10.1002/cbic.201600274 · Cited by 10
Epigenomic Consequences of Coding and Noncoding Driver Mutations
Yao, X., Xing, M., Ooi, W. F., Tan, P. B. O., & Teh, B. T. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.09.002 · Cited by 11
Focused conformational sampling in proteins
Bacci, M., Langini, C., Vymětal, J., Caflisch, A., & Vitalis, A. (2017) · The Journal of Chemical Physics · doi:10.1063/1.4996879 · Cited by 10
Lysine acetylation as drug target in fungi: an underexplored potential in Aspergillus spp.
Wassano, N. S., Leite, A. B., Reichert‐Lima, F., Schreiber, A. Z., Moretti, N. S., & Damásio, A. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00253-w · Cited by 12
“Epigenetic mechanisms, including histone modifications that directly affect chromatin structure, such as methylation, phosphorylation, and acetylation, have been widely explored for the development of new treatments for cancer and inflammatory, immunological, and neurodegenerative diseases [10], but they have been les…”
BackgroundEpigenetics during EMT in lung cancer: EZH2 as a potential therapeutic target
Dimou, A., Dincman, T. A., Evanno, E., Gemmill, R. M., Roche, J., & Drabkin, H. A. (2017) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2017.06.003 · Cited by 11
PRMT4 bound with a bicyclic compound
Xiong, B., Cao, D. Y., Guo, Z. H., Li, Y. L., Li, J., Huang, X., & Shen, J. K. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6izq/pdb · Cited by 10
Marine natural product-inspired discovery of novel BRD4 inhibitors with anti-inflammatory activity
Chen, S., Yang, J., Wang, X., Liu, X., Li, X., Ye, Y., Wang, P., Liu, Z., & Wang, C. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117193 · Cited by 9
Micro-editing mistake translates into a devastating brain tumor
Dominissini, D., Amariglio, N., & Rechavi, G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci66178 · Cited by 10
Recent Advances in Small-Molecule Modulation of Epigenetic Targets
Sweis, R. F., & Michaelides, M. R. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00013-2 · Cited by 9
Zhang, M., Luo, X., Zhang, C., Wang, C., Wu, X., Xiang, Q., Xu, Y., & Zhang, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00881-y · Cited by 9
“Thus, the bromodomain-containing proteins act as epigenetic “readers” by binding to KAc via the bromodomain to regulate gene expression [1].”
BackgroundEpigenetics and Cutaneous Neoplasms: From Mechanism to Therapy
Gibson, F. T., Hanly, A. M., Fisher, R. J., Wyant, W. A., Wu, M., Collard, M., & Alani, R. M. (2023) · Epigenomics · doi:10.2217/epi-2023-0016 · Cited by 10
Tang, H., Liang, Y., Yu, M., Cai, S., Ding, K., & Wang, Y. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117437 · Cited by 9
Dai, L., Tan, C., Wang, H., Wang, L., Zhang, T., Zhi, S., Yang, Z., Zhao, X., & Li, D. (2023) · ChemMedChem · doi:10.1002/cmdc.202300467 · Cited by 9
Cho, M., Choi, E., Kim, J. H., Kim, H., Kim, H. M., Lee, J. I., Hwang, K., Kim, H. J., & Han, G. (2013) · ChemMedChem · doi:10.1002/cmdc.201300393 · Cited by 9
Zhang, W., Coba, M. P., & Sun, F. (2016) · BMC Systems Biology · doi:10.1186/s12918-015-0247-y · Cited by 11
“Most of the identified loci, however, represent novel discoveries with no obvious candidate genes and molecular mechanisms [4], rendering difficulties in medical treatment according to genes [5 – 7].”
BackgroundZhou, H., Che, X., Bao, G., Wang, N., Peng, L., Barnash, K. D., Frye, S. V., James, L. I., & Bai, X. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.08.004 · Cited by 9
How to Train a Cell–Cutting-Edge Molecular Tools
Czapiński, J., Kiełbus, M., Kałafut, J., Kos, M., Stepulak, A., & Rivero‐Müller, A. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00012 · Cited by 10
“…TET hydroxylases, while histones are acetylated by histone acetyltransferases (HATs), deacetylated by histone deacetylases (HDACs), methylated by histone methyl-transferases (HMTs) and demethylated by histone demethylases (HDMs) (Arrowsmith et al., 2012; Kooistra and Helin, 2012; Jin et al., 2015).”
BackgroundRia, F., Pirolli, D., Sante, G. D., Righino, B., Gremese, E., Gervasoni, J., Nicolò, C., Giardina, B., Ferraccioli, G., & Rosa, M. C. D. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00601 · Cited by 9
Epigenetic Mechanisms Underlying Pathobiology of Alcohol Use Disorder
Dulman, R. S., Wandling, G. M., & Pandey, S. C. (2020) · Current Pathobiology Reports · doi:10.1007/s40139-020-00210-0 · Cited by 15
4‐Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading
Lucas, X., Wohlwend, D., Hügle, M. J., Schmidtkunz, K., Gerhardt, S., Schüle, R., Jung, M., Einsle, O., & Günther, S. (2013) · Angewandte Chemie · doi:10.1002/ange.201307652 · Cited by 9
Targeting chromatin to improve radiation response
Olcina, M. M., O’Dell, S. D., & Hammond, E. M. (2014) · British Journal of Radiology · doi:10.1259/bjr.20140649 · Cited by 9
Histone Post-translational Modifications to Target Memory-related Diseases
Monti, B. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319280005 · Cited by 9
“Selective interactions between neighboring histones are also regulated by PTMs [28, 32, 33].”
BackgroundProton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures
Ramachandran, G. K., & Yeow, C. (2017) · Biological Research · doi:10.1186/s40659-017-0117-8 · Cited by 9
“Methylated amino acids especially methyl-lysine and methyl-arginine in the chromatin plays a vital role in recruiting proteins that induce structural changes in chromatin thus influencing gene expression and repression [53].”
BackgroundMinh, N. V., Thanh, N. T., Lien, H. T., Anh, D. T. P., Cuong, H. D., Nam, N., Pham‐The, H., Minh-Ngoc, L., Le‐Thi‐Thu, H., Chinh, L. V., et al. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190702142654 · Cited by 10
Osko, J. D., & Christianson, D. W. (2020) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x20010250 · Cited by 9
Wang, L., Bao, X., Yang, J., Li, H., Zhou, Q., Jiang, X., Li, M., Liu, X., Yuan, X., Sun, Y., et al. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.02.018 · Cited by 9
C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels
Shi, Y., Ma, H., Zhuang, Y., Wang, X., Jiang, Y., & Xu, H. E. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0247-3 · Cited by 11
Epigenetic Medicinal Chemistry.
Copeland, R. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00462 · Cited by 9
Epigenetic reader chromodomain as a potential therapeutic target
Sharma, S., Hampton, J. T., Kutateladze, T. G., & Liu, W. R. (2025) · RSC Chemical Biology · doi:10.1039/d4cb00324a · Cited by 8
Role of Additional Novel Therapies in Myeloproliferative Neoplasms
Fiskus, W. C., Ganguly, S., Kambhampati, S., & Bhalla, K. N. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.07.001 · Cited by 9
Targeting the Bet Family for the Treatment of Leukemia
Lucas, X., & Günther, S. (2014) · Epigenomics · doi:10.2217/epi.14.5 · Cited by 9
Multistage modeling of protein dynamics with monomeric Myc oncoprotein as an example
Liu, J., Dai, J., He, J., Niemi, A. J., & Ilieva, N. (2017) · Physical review. E · doi:10.1103/physreve.95.032406 · Cited by 8
Han, Q., Chen, F., Liu, S., Ge, Y., Wu, J., & Liu, D. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03528-9 · Cited by 8
Kong, S. J., Nam, G., Boggu, P. R., Park, G. M., Kang, J.-E., Park, H., & Jung, Y. H. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117154 · Cited by 9
HDAC Inhibitor Titration of Transcription and Axolotl Tail Regeneration
Voss, S. R., Smith, J. J., Cecil, R. F., Kabangu, M., Duerr, T. J., Monaghan, J. R., Timoshevskaya, N. Y., Ponomareva, L. V., Thorson, J. S., Veliz‐Cuba, A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.767377 · Cited by 8
“Alternatively, small molecules can be used to specifically alter the activities of regulatory proteins to interrogate mechanisms of transcriptional regulation (Yeh and Crews, 2003; Arrowsmith et al., 2012).”
BackgroundStructural and Functional Attributes of Microrchidia Family of Chromatin Remodelers
Chutani, N., Singh, A. K., Kadumuri, R. V., Pakala, S. B., & Chavali, S. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167664 · Cited by 9
Structural classification of EZH2 inhibitors and prospects for the treatment of tumor: a review
Yu, L., Xia, M.-T., Wang, Y., Yan, Z., Zhang, L., & Li, S. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-023-03105-y · Cited by 8
Genetic and Epigenetic Regulation in Age-Related Macular Degeneration
Wei, L., Chen, P., Lee, J. H., & Nussenblatt, R. B. (2013) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31829e2793 · Cited by 8
“In particular, enzymes and proteins mediating histone acetylation and methylation are extensively studied, including HATs and their inhibitors (histone deacetylases [HDACs]), as well as histone methyltransferases and demethylases.(69) Recent studies strongly suggest a crosstalk between DNA methylation and histone modi…”
BackgroundStructure and binding properties of a cameloid nanobody raised against KDM5B
Wiuf, A., Kristensen, L. H., Kristensen, O., Dorosz, J., Jensen, J., & Gajhede, M. (2015) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x1501537x · Cited by 8
“The histone demethylase (HDM) class of enzymes appear to play a key role in the regulation of known oncogenes (Chi et al., 2010; Arrowsmith et al., 2012).”
BackgroundEpigenetic Regulation in Heart Failure: Part II DNA and Chromatin
DiSalvo, T. G. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000074 · Cited by 9
“Pharmacologic modulation of histone acetylation is an attractive potential therapeutic strategy given the central importance of histone acetylation in cell hypertrophy and tissue remodeling.(89) Small molecule HDAC inhibitors are divided into 4 different structural groups: hydroxamic acids (eg, trichostatin A) suberoy…”
BackgroundKnuhtsen, A., Legrand, B., der Poorten, O. V., Amblard, M., Martínez, J., Ballet, S., Kristensen, J. L., & Pedersen, D. S. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602518 · Cited by 8
Song, D., Lee, C., Kook, Y. J., Oh, S. J., Kang, J. S., Kim, H. J., & Han, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.055 · Cited by 8
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors
Sun, Y., Lv, R., Wu, T., Zhang, X., Sun, Y., Yan, J., Zhang, Z., Zhao, D., & Cheng, M. (2021) · Archiv der Pharmazie · doi:10.1002/ardp.202100311 · Cited by 8
Identification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry
Ramachandran, G. K., Yong, W. P., & Yeow, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162222 · Cited by 8
“Methylated amino acids especiallymethyl-lysine and methylarginine in the chromatin plays a vital role in recruiting proteins that induce structural changes in chromatin thus influencing gene expression and repression [63].”
BackgroundDiscovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor
Xiong, Y., Greschik, H., Johansson, C., Seifert, L., Gamble, V., Park, K., Fagan, V., Li, F., Chau, I., Vedadi, M., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00121 · Cited by 7
Self-citationYu, Y., Yu, X., Pan, B., Chan, H. M., Kanıskan, H. Ü., Jin, J. J., Cai, L., & Wang, G. G. (2025) · Science Advances · doi:10.1126/sciadv.ads7876 · Cited by 11
“With the advent of drugs targeting specific epigenetic pathways, harnessing the cancer-related epi-targets emerges as an attractive and promising therapeutic strategy ( 47 , 49 , 52 , 53 ).”
Ariawan, D., Mansour, F., Richardson, N., Bhadbhade, M. M., Ho, J., & Hunter, L. (2021) · Molecules · doi:10.3390/molecules26133974 · Cited by 7
“Introduction Histone deacetylases (HDACs) are important enzymes whose functions include the regulation of gene expression [1].”
BackgroundTargeting histone methylation and demethylation for non-alcoholic fatty liver disease
Du, Y., He, Z., Jin, S., Jin, G. Y., Wang, K., Yang, F., & Zhang, J. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107698 · Cited by 7
DNMT3a promotes LUAD cell proliferation and metastasis by activating the HDAC7 signalling pathway
Jiang, M., Zhou, X., Feng, Y., Ding, P., Li, J., Lu, D., Qin, J., Bai, Y., Wang, A., Xia, C., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.96509 · Cited by 9
“Studies have shown that simultaneous targeting of DNA methylation and histone deacetylation leads to additive or synergistic effects to reactivate abnormally silenced genes[46].”
Therapeutics Targeting Protein Acetylation Perturb Latency of Human Viruses
Conrad, R. J., & Ott, M. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00999 · Cited by 8
“At this time, epigenetic drugs targeting protein acetylation, a posttranslational modification best studied with regard to histones, are the most clinically advanced((8)).”
BackgroundGenetic and Epigenetic Targets of Natural Dietary Compounds as Anticancer Agents
Shi, Q., Bishayee, A., & Bhatia, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812494-9.00001-9 · Cited by 7
Getting a Handle on Chemical Probes of Chomatin Readers
Waybright, J. M., & James, L. I. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0274 · Cited by 7
Kalra, P., McGraw, L., Kimbrough, J. R., Pandey, A. K., Solberg, J. C., Cui, H., Divakaran, A., John, K., Hawkinson, J. E., & Pomerantz, W. C. K. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00720 · Cited by 7
Marastoni, E., Bartoli, S., Berettoni, M., Cipollone, A., Ettorre, A., Fincham, C. I., Mauro, S., Paris, M., Porcelloni, M., Bigioni, M., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.02.007 · Cited by 7
Shi, G., Yoshida, Y., Yuki, K., Nishimura, T., Kawata, Y., Kawashima, M., Iwaisako, K., Yoshikawa, K., Kurebayashi, J., Toi, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8620 · Cited by 10
Sekirnik, A. R., Hewings, D. S., Theodoulou, N. H., Jursins, L., Lewendon, K. R., Jennings, L. E., Rooney, T. P. C., Heightman, T. D., & Conway, S. J. (2016) · Angewandte Chemie · doi:10.1002/ange.201602908 · Cited by 7
Epigenetic Coregulation of Androgen Receptor Signaling
Fernandes, R. C., Leach, D. A., & Bevan, C. L. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_16 · Cited by 8
Chemical Biology Approaches for Characterization of Epigenetic Regulators
Baršytė-Lovejoy, D., Szewczyk, M., Prinos, P., Lima‐Fernandes, E., Ackloo, S. Z., & Arrowsmith, C. H. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.01.011 · Cited by 7
“Interestingly, many of what were initially called histone-specific proteins have since been shown to also modify or bind nonhistone substrates involved in transcription, splicing, and metabolism (Barsyte-Lovejoy et al., 2014; Mazur et al., 2014; Scholz et al., 2015; Zhu et al., 2015).”
BackgroundSelf-citationStructure-Based Design and Computational Studies of Sirtuin Inhibitors
Karaman, B., Jung, M., & Sippl, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802808-7.00011-3 · Cited by 8
Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity
Lee, H., Kim, B.-K., Yoon, K. B., Kim, Y., & Han, S. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0496-2 · Cited by 7
“Vorinostat, romidepsin, belinostat, and panobinostat are HDAC inhibitors that have been approved as anticancer drugs [16].”
BackgroundBaedke, J. (2017) · Routledge eBooks · doi:10.4324/9781315440842-3 · Cited by 7
Novel pyrano 1,3 oxazine based ligand inhibits the epigenetic reader hBRD2 in glioblastoma
Deshmukh, P. H., Mathur, S., Gangadharan, G., Krishnappa, G., Nanjaiah, N. D., & Padmanabhan, B. (2020) · Biochemical Journal · doi:10.1042/bcj20200339 · Cited by 8
Non-bonding energy directed designing of HDAC2 inhibitors through molecular dynamics simulation
Dewaker, V., Srivastava, P. N., Verma, S. K., Srivastava, A. K., & Prabhakar, Y. S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1989037 · Cited by 7
“Among these, Class I (HDAC 1, 2, 3, and 8), Class II (IIa—HDAC 4, 5, 7 and 9; IIb—HDAC 6 and 10), and Class IV (11) HDACs are zinc (Zn2þ) dependent classical HDACs (Arrowsmith et al., 2012; Johnstone, 2002).”
BackgroundOstrop, J., Zwiggelaar, R. T., Pedersen, M. T., Gerbe, F., Bösl, K., Lindholm, H. T., Díez-Sánchez, A., Parmar, N., Radetzki, S., von Kries, J. P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.23.217414 · Cited by 7
“J Biol Chem, 284(14):9168–9175, April 2009.”
Self-citationDesign and synthesis of novel bispecific molecules for inducing BRD4 protein degradation
Wang, S., Song, Y., Wang, Y., Gao, Y., Yu, S., Zhao, Q., Jin, X., & Lu, H. (2018) · Chemical Research in Chinese Universities · doi:10.1007/s40242-018-7272-5 · Cited by 6
Jana, A., Naga, R., Saha, S., Griñán‐Ferré, C., & Banerjee, D. R. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2213346 · Cited by 6
“…of proteins are involved in the PTMs—(I) “writers” (proteins that construct PTMs in the histone tail), (II) “readers” (proteins that acknowledge the existence of PTMs), (III) “erasers” (proteins that delete the modification from the histone tail) (Arrowsmith et al., 2012; Kaniskan et al., 2018).”
BackgroundScaffolding Activities of Pseudodeacetylase HDAC7
Kodikara, I. K. M., & Pflum, M. K. H. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.4c00753 · Cited by 9
Research progress on m6A and drug resistance in gastrointestinal tumors
Xu, Z., Sun, B., Wang, W. W., Fan, Y., Su, J., Sun, J., & Gu, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1565738 · Cited by 6
“These mechanisms play important roles in regulating gene expression, cell fate decisions, and response to environmental stimuli, and the occurrence of epigenetic abnormalities is often an important driver of cancer development (Arrowsmith et al., 2012; An and Duan, 2022).”
Challenges in profiling and lead optimization of drug discovery for methyltransferases
Horiuchi, K. Y. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.10.010 · Cited by 6
“Introduction Epigenetic modifications are dynamic and reversible processes that establish normal cellular phenotypes, but also contribute to human diseases [1].”
BackgroundRojas‐Rojas, F. U., & Vega‐Arreguín, J. (2021) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12954 · Cited by 8
Structure-function conservation between the methyltransferases SETD3 and SETD6
Admoni-Elisha, L., Abaev-Schneiderman, E., Cohn, O., Shapira, G., Shomron, N., Feldman, M., & Levy, D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.003 · Cited by 6
Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Giry-Laterrière, M., Pinho, A. V., Eling, N., Chantrill, L. A., & Rooman, I. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150512102957 · Cited by 6
A salt bridge turns off the foot-pocket in class-II HDACs
Zhou, J., Yang, Z., Zhang, F., Luo, H., Li, M., & Wu, R. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp03144g · Cited by 6
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Simões‐Pires, C. A., Zwick, V., Cretton, S., & Cuendet, M. (2017) · Journal of Visualized Experiments · doi:10.3791/55878 · Cited by 6
Genome-Wide Perspectives on Vitamin D Receptor–Mediated Control of Gene Expression in Target Cells
Pike, J. W., Meyer, M. B., Lee, S. M., Onal, M., & Benkusky, N. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00009-4 · Cited by 6
Metadata
- Authors
- Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M.
- Affiliations
- University of Toronto (CA)
- University of Oxford (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Corresponding author
- Arrowsmith, Cheryl H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-04-13
- Volume
- 11
- Issue
- 5
- Pages
- 384-400
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2076333986
- Semantic Scholar
- fd3346db3efdf967ef263b7d902523d5edecb53e
- Cited by
- 1,327
- References
- 194
- Citations by year
- 2026: 29 · 2025: 49 · 2024: 47 · 2023: 47 · 2022: 62 · 2021: 85 · 2020: 103 · 2019: 103 · 2018: 93 · 2017: 126 · 2016: 165 · 2015: 132 · 2014: 115 · 2013: 116 · 2012: 54
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Genome Canada
- Wellcome Trust (1097737)
- Ontario Genomics
- Ontario Genomics Institute
- Canadian Institutes of Health Research (1097737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- epigenetic regulation, histone acetylation, histone methylation, histone deacetylase, protein methyltransferases, lysine demethylase, bromodomain proteins, epigenetic drug targets, epigenetic drug discovery, cancer, inflammation, neuropsychiatric disorders
- MeSH terms
- Acetylation, Animals, Gene Expression Regulation, Histones, Humans, Methylation, Protein Binding, Proteins, Signal Transduction, Epigenesis, Genetic, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.